Cargando…
Immunodominant PstS1 antigen of mycobacterium tuberculosis is a potent biological response modifier for the treatment of bladder cancer
BACKGROUND: Bacillus Calmette Guérin (BCG)-immunotherapy has a well-documented and successful clinical history in the treatment of bladder cancer. However, regularly observed side effects, a certain degree of nonresponders and restriction to superficial cancers remain a major obstacle. Therefore, al...
Autores principales: | Sänger, Christian, Busche, Andreas, Bentien, Gabriele, Spallek, Ralf, Jonas, Fatima, Böhle, Andreas, Singh, Mahavir, Brandau, Sven |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544192/ https://www.ncbi.nlm.nih.gov/pubmed/15566565 http://dx.doi.org/10.1186/1471-2407-4-86 |
Ejemplares similares
-
The M. tuberculosis Phosphate-Binding Lipoproteins PstS1 and PstS3 Induce Th1 and Th17 Responses That Are Not Associated with Protection against M. tuberculosis Infection
por: Palma, Carla, et al.
Publicado: (2011) -
Structure–Function Aspects of PstS in Multi-Drug–Resistant Pseudomonas aeruginosa
por: Zaborina, Olga, et al.
Publicado: (2008) -
Polymorphism of MPT64 and PstS1 in Mycobacterium tuberculosis is not likely to affect relative immune reaction in human
por: Xiao, Tongyang, et al.
Publicado: (2019) -
Mechanisms Underlying the Virulence Regulation of Vibrio alginolyticus ND-01 pstS and pstB with a Transcriptomic Analysis
por: Yi, Xin, et al.
Publicado: (2022) -
Localization of DING proteins on PstS-containing outer-surface appendages of Pseudomonas aeruginosa
por: Shah, Megha, et al.
Publicado: (2014)